November 2023

WAKEFIELD, Mass., Nov. 7, 2023 /PRNewswire/ — Myrtelle Inc. (“Myrtelle” or the “Company”), a clinical-stage gene therapy company focused on developing transformative treatments for neurodegenerative diseases, today announced that Christopher Janson, M.D., Principal Inv

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: